Jonathan Rabinowitz, PhD

Original Research

Determinants of Antipsychotic Response in Schizophrenia: Implications for Practice and Future Clinical Trials

April 15, 2014

Original Research

BL-1020, a New γ-Aminobutyric Acid-Enhanced Antipsychotic: Results of 6-Week, Randomized, Double-Blind, Controlled, Efficacy and Safety Study

September 15, 2012

Original Research

Behavioral and Psychological Symptoms in Patients With Dementia as a Target for Pharmacotherapy With Risperidone

October 15, 2004

Original Research

Rapid Onset of Therapeutic Effect of Risperidone Versus Haloperidol in a Double-Blind Randomized Trial

May 1, 2001